nodes	percent_of_prediction	percent_of_DWPC	metapath
Naftifine—Terbinafine—CYP1A2—chronic obstructive pulmonary disease	0.0433	0.107	CrCbGaD
Naftifine—Cinacalcet—CYP1A2—chronic obstructive pulmonary disease	0.0417	0.103	CrCbGaD
Naftifine—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.0364	0.061	CcSEcCtD
Naftifine—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.0364	0.061	CcSEcCtD
Naftifine—Duloxetine—SLC6A4—chronic obstructive pulmonary disease	0.0359	0.0888	CrCbGaD
Naftifine—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.035	0.0865	CrCbGaD
Naftifine—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.0343	0.0576	CcSEcCtD
Naftifine—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.0337	0.0834	CrCbGaD
Naftifine—Duloxetine—CYP1A2—chronic obstructive pulmonary disease	0.0327	0.0809	CrCbGaD
Naftifine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.0291	0.0721	CrCbGaD
Naftifine—Duloxetine—HTR2A—chronic obstructive pulmonary disease	0.0276	0.0683	CrCbGaD
Naftifine—Blister—Prednisolone—chronic obstructive pulmonary disease	0.0265	0.0445	CcSEcCtD
Naftifine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.0246	0.0608	CrCbGaD
Naftifine—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.0236	0.0396	CcSEcCtD
Naftifine—Cinnarizine—CYP1A1—chronic obstructive pulmonary disease	0.02	0.0494	CrCbGaD
Naftifine—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.0199	0.0494	CrCbGaD
Naftifine—Cinnarizine—CYP1A2—chronic obstructive pulmonary disease	0.0193	0.0477	CrCbGaD
Naftifine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0164	0.0275	CcSEcCtD
Naftifine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0156	0.0262	CcSEcCtD
Naftifine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0156	0.0262	CcSEcCtD
Naftifine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0155	0.0261	CcSEcCtD
Naftifine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.0145	0.0243	CcSEcCtD
Naftifine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.014	0.0346	CrCbGaD
Naftifine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.0138	0.0342	CrCbGaD
Naftifine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.0135	0.0333	CrCbGaD
Naftifine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0117	0.0196	CcSEcCtD
Naftifine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.011	0.0185	CcSEcCtD
Naftifine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0109	0.0183	CcSEcCtD
Naftifine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0108	0.0181	CcSEcCtD
Naftifine—Pain—Formoterol—chronic obstructive pulmonary disease	0.0108	0.0181	CcSEcCtD
Naftifine—Pain—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0177	CcSEcCtD
Naftifine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0104	0.0175	CcSEcCtD
Naftifine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0104	0.0175	CcSEcCtD
Naftifine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0104	0.0174	CcSEcCtD
Naftifine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0103	0.0173	CcSEcCtD
Naftifine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0102	0.017	CcSEcCtD
Naftifine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00983	0.0165	CcSEcCtD
Naftifine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00982	0.0165	CcSEcCtD
Naftifine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00977	0.0164	CcSEcCtD
Naftifine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0089	0.0149	CcSEcCtD
Naftifine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0089	0.0149	CcSEcCtD
Naftifine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00872	0.0146	CcSEcCtD
Naftifine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0084	0.0141	CcSEcCtD
Naftifine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00835	0.014	CcSEcCtD
Naftifine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00832	0.014	CcSEcCtD
Naftifine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00832	0.014	CcSEcCtD
Naftifine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00815	0.0137	CcSEcCtD
Naftifine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00793	0.0133	CcSEcCtD
Naftifine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00793	0.0133	CcSEcCtD
Naftifine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00792	0.0133	CcSEcCtD
Naftifine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00792	0.0133	CcSEcCtD
Naftifine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00788	0.0132	CcSEcCtD
Naftifine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00788	0.0132	CcSEcCtD
Naftifine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00786	0.0132	CcSEcCtD
Naftifine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00777	0.013	CcSEcCtD
Naftifine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00776	0.013	CcSEcCtD
Naftifine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00772	0.013	CcSEcCtD
Naftifine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00749	0.0126	CcSEcCtD
Naftifine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00748	0.0126	CcSEcCtD
Naftifine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00744	0.0125	CcSEcCtD
Naftifine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00607	0.0102	CcSEcCtD
Naftifine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00583	0.00978	CcSEcCtD
Naftifine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00451	0.00756	CcSEcCtD
Naftifine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0043	0.00721	CcSEcCtD
Naftifine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0072	CcSEcCtD
Naftifine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00427	0.00716	CcSEcCtD
Naftifine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0035	0.00588	CcSEcCtD
Naftifine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00327	0.00549	CcSEcCtD
Naftifine—Rash—Prednisone—chronic obstructive pulmonary disease	0.00312	0.00524	CcSEcCtD
Naftifine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00312	0.00523	CcSEcCtD
Naftifine—Headache—Prednisone—chronic obstructive pulmonary disease	0.0031	0.0052	CcSEcCtD
